Currently, only 30 percent of insurers will cover these medications, another way weight stigma and the misconception that obesity is purely a lifestyle issue continues to harm people
This release aligns with increasing demand from informed consumers who seek clarity around how products are built, how bacterial strains are sourced, and how different gut health elements function together
While tirzepatide is not approved as a treatment for hypertension, many patients with obesity-related high blood pressure experience improvements during treatment
Katelyn Brown, Xuewei Cui, Ciara O Neill, Laura Fernndez Land and Hiren Patel are employees and shareholders of Eli Lilly and Company
But for some, it remains disruptive enough to cause dose reductions or treatment discontinuation